Follow The Filings

INVX Innovex International

Innovex International earnings company data as of 11:08 PM ET 11/17

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.37 — —
Rev $257.7M $265.1M Beat +2.8%

Insider trades

Open-market buys and sales by INVX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INVX insider trades
  • None no insider bought on the open market
  • $306M sold by 2 insiders outside a trading plan
  • $309M sold by 5 insiders under 10b5-1 plans
  1. Mark Reddout President of North America
    Planned sale
    $150 6 shares at $25.00 <0.1% of stake
    Traded Nov 16 Filed Nov 18
  2. Kendal Reed CFO
    Planned sale
    $523K 20,868 shares at $25.04 10% of stake
    Traded Nov 12 Filed Nov 13
  3. Innovex Co-Invest Fund, L.P. Director, +8 joint filers
    Sale
    $144M 5,000,000 shares at $28.71 97% of stake
    Traded Aug 10 Filed Aug 10
  4. Mark Reddout President of North America
    Planned sale
    $300K 10,000 shares at $30.00 7.4% of stake
    Traded Aug 4 Filed Aug 5
  5. Mark Reddout President of North America
    Planned sale
    $301K 10,750 shares at $28.00 7.4% of stake
    Traded Jun 2 Filed Jun 3
  6. Amberjack Capital Partners, L.P. Director, +8 joint filers
    Sale
    $163M 6,612,500 shares at $24.59 97% of stake
    Traded Feb 27 Filed Feb 27
  7. Adam Anderson CEO
    Planned sale
    $537K 18,837 shares at $28.50 3.9% of stake
    Traded Feb 24 Filed Feb 25
  8. Adam Anderson CEO
    Planned sale
    $358K 13,241 shares at $27.00 2.7% of stake
    Traded Feb 23 Filed Feb 24
  9. Mark Reddout President of North America
    Planned sale
    $500K 20,000 shares at $25.00 13% of stake
    Traded Jan 14 Filed Jan 15
  10. Adam Anderson CEO
    Planned sale
    $331K 13,241 shares at $25.00 2.6% of stake
    Traded Jan 14 Filed Jan 15

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants and 11 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
424B7
8-K 1.01,9.01
424B7
10-Q
8-K 2.02,7.01,9.01
8-K/A 3.02
8-K 3.02
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 5.07
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf